Connect with us

NEWS

Scientists link vitamin K deficiency to coronavirus deaths

Published

on

SCIENTISTS in Netherlands have explored possible link between Vitamin K deficiency and COVID-19 deaths.

  Researchers studying patients who were admitted to the Canisius Wilhelmina Hospital in the Dutch city of Nijmegen extolled the benefits of vitamin K after discovering a link between its deficiency and the worst coronavirus outcomes.

  According to them, COVID-19 causes blood clotting and leads to the degradation of elastic fibres in the lungs. Vitamin K, which is ingested through food and absorbed in the gastrointestinal tract, is key to the production of proteins that regulate clotting and could protect against lung disease

  The Dutch researchers are now seeking funding for a clinical trial, but Dr Rob Janssen, a scientist working on the project, said that in light of the initial findings, he would encourage a healthy intake of vitamin K, except to those on blood-clotting medications such as warfarin.

  He said: “We are in a terrible, horrible situation in the world. We do have an intervention which does not have any side effects, even less than a placebo. There is one major exception: people on anti-clotting medication. It is completely safe in other people.

  “My advice would be to take those vitamin K supplements. Even if it does not help against severe COVID-19, it is good for your blood vessels, bones and probably also for the lungs.”

Janssen added: “We have vitamin K1 and K2.. K1 is in spinach, broccoli, green vegetables, blueberries, all types of fruit and vegetables. K2 is better absorbed by the body. It is in Dutch cheese, I have to say and French cheese as well.”

  A Japanese delicacy of fermented soya beans called natto is particularly high in the second type of vitamin K and there may be cause for further studies into its health benefits, Janssen said.

  “I have worked with a Japanese scientist in London and she said it was remarkable that in the regions in Japan where they eat a lot of natto, there is not a single person to die of Covid-19; so that is something to dive into, I would say.”

  The research, undertaken in partnership with the Cardiovascular Research Institute Maastricht, one of Europe’s largest heart and vascular research institutes, studied 134 patients hospitalised for COVID-19 between 12th March and 11th April, alongside a control group of 184 age-matched patients who did not have the disease.

  Jona Walk, a second researcher on the study, which was submitted for peer review last friday, said: “We want to take very sick COVID-19 patients and randomise so that they get a placebo or vitamin K, which is very safe to use in the general population. We want to give vitamin K in a significantly high enough dose that we really will activate the protein that is so important for protecting the lungs, and check if it is safe.”

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending